Title Immune response to COVID-19 in older adults.
Author Jergovic, Mladen; Coplen, Christopher P; Uhrlaub, Jennifer L; Nikolich-Zugich, Janko
Journal J Heart Lung Transplant Publication Year/Month 2021-Oct
PMID 34140221 PMCID PMC8111884
Affiliation + expend 1.Department of Immunobiology, University of Arizona College of Medicine-Tucson, Tucson, Arizona; University of Arizona Center on Aging, University of Arizona College of Medicine-Tucson, Tucson, Arizona. Electronic address: mjergovic@arizona.edu.

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the third highly pathogenic coronavirus to emerge in the human population in last two decades. SARS-CoV-2 spread from Wuhan, China, across the globe, causing an unprecedented public healthcare crisis. The virus showed remarkable age dependent pathology, with symptoms resembling common cold in most adults and children while causing more severe respiratory distress and significant mortality in older and frail humans. Even before the SARS-CoV-2 outbreak infectious diseases represented one of the major causes of death of older adults. Loss of immune function and reduced protection from infectious agents with age - immunosenescence - is a result of complex mechanisms affecting production and maintenance of immune cells as well as the initiation, maintenance and termination of properly directed immune responses. Here we briefly discuss the current knowledge on how this process affects age-dependent outcomes of SARS-CoV-2 infection.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.